Pepto Bismol didn't prevent travelers' diarrhea compared to placebo, small CDC study found
How gut health can impact more than just the stomach
Bismuth subsalicylate, the active ingredient in Pepto Bismol, is often used to treat and prevent diarrhea while traveling — but a new study found it may not help with prevention.
In the study from the Centers for Disease Control and Prevention, "no significant difference" was found for symptoms of loose stool or diarrhea between groups who took the medication for prevention and those who took a placebo.
Since 1939, bismuth subsalicylate has been approved by the Food and Drug Administration for the treatment of diarrhea, heartburn, indigestion, nausea and upset stomach. But, as the authors note, it's also used off-label for the prevention of diarrhea, especially among international travelers.
The study issued questionnaires before, during and after travel to the 270 participants, who had a median age of 32 and planned to travel to Southeast Asia, south central Asia, North Africa or sub-Saharan Africa for 7 to 21 days. Participants were recruited from clinical sites in New York in Massachusetts.
The group given the medication took 4 tablets twice daily during their trip.
The study did have limitations, including not reaching the target sample size. But it did provide the first new data since the 1980s on the potential use of bismuth subsalicylate in diarrhea prevention, according to the study's authors.
"Despite this study not reaching the targeted sample size, there are nonetheless important considerations for healthcare providers conducting pretravel consultations for international travelers," the authors wrote.
The authors also noted further studies are needed to determine if there is a benefit in certain traveler groups or under certain circumstances.
"A larger study might show benefit, although the benefit may be small given the results of this study," they wrote.
Procter & Gamble, the parent company of Pepto Bismol, provided the medication for the study but did not participate in any procedures, the authors noted.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Boston Globe
30 minutes ago
- Boston Globe
What's going on with measles, bird flu, and COVID? Here's a guide to the latest.
Write to us at . To subscribe, . TODAY'S STARTING POINT Measles outbreaks. A canceled effort to develop a bird flu vaccine. An infectious new COVID variant and changing federal guidance about who should get boosted. In recent weeks, drama in D.C. has buried several vaccine-related developments. Today's newsletter explains what's new and what it means. COVID What's changed: Last month, health secretary Robert F. Kennedy Jr. What it means: The administration has tried to narrow the pool of people it says should get boosted. But where some of the changes reflect reasonable readings of the science, others do not. Advertisement Dr. Nirav Shah, a top CDC official during the Biden administration, said experts debate whether younger children should get boosted. When Shah was in government, he recommended it. But many other countries don't, noting that most young children have a low risk of serious illness. The mRNA technology used in some COVID shots can also have side effects, including a condition called myocarditis that mostly affects boys and young men. Advertisement But Shah, who previously led Maine's CDC and is now at Colby College, says the evidence is much less debatable in the case of pregnant women. Not only are boosters safe and effective for them, but getting them protects babies in utero and up to 6 months old The way Kennedy made the changes has also troubled experts. Normally, health agencies gather outside advisers' input before making new recommendations. But Kennedy seems to have acted unilaterally. His announcement, made in a minutelong social media video, 🎁 ). 'What it suggests is that some of the conclusions are foregone,' Shah said. Kennedy argues that health experts made mistakes that undermined public trust during the pandemic. Shah acknowledges that, to a point. Some experts, he said, tried to squelch dissenting views or didn't effectively communicate that scientists' understanding of COVID would evolve, causing confusion when public health guidance changed. Other experts overstated 🎁 ). But the administration's approach risks sowing further confusion. Kennedy's announcement conflicts with an article that two Trump-appointed FDA officials published days earlier, which listed pregnancy as one factor that puts women ' 'What worries me is that when we get into another emergency situation, if trust in federal health authorities has waned, that's a problem,' Shah said. Advertisement Meanwhile, COVID keeps evolving. A variant called NB.1.8.1 has recently driven up cases in China and elsewhere. But for now, Shah isn't hugely concerned. NB.1.8.1 descended from Omicron, a variant that swept the United States in late 2021 and early 2022. So even if cases rise, existing vaccines and antibodies from prior infection will likely help protect against severe illness. The World Health Organization says the new variant ' Bird flu What's changed: A few months ago, bird flu was spreading rapidly among cows and chickens, What it means: Bird flu may be seasonal, which Given the uncertainty, some experts have faulted the administration for Advertisement Measles What's changed: Cases of the highly contagious virus continue to rise nationwide, but slowly. The largest outbreak, in West Texas, seems to be abating. Three Americans have died this year, all unvaccinated. What it means: A slowing case rate is good news, although many more people could have gotten sick than the official numbers reflect. The measles vaccine is safe, highly effective, and decades old, but Kennedy was slow to full-throatedly recommend it as the outbreak grew. 🧩 3 Down: 90° POINTS OF INTEREST Bob Lamb, who operates his gunsmithing business out of his garage in Cheshire, Mass., says the area has a "hunting culture." Erin Clark/Globe Staff Boston War of words: The US attorney for Massachusetts accused Boston Mayor Michelle Wu of making ' Dueling claims: Democratic activists asked a state agency to investigate Josh Kraft's mayoral campaign for allegedly Secret proceedings: A closed hearing begins in Boston today to determine whether a former Stoughton police deputy chief should lose his ability to work as an officer Evolving: A Boston nonprofit that launched after George Floyd's murder is navigating a backlash to Massachusetts and New England Karen Read retrial: The defense called a snowplow driver, who testified that he Market Basket case: Who's who in the latest Proxy fight: Representative Stephen Lynch of Massachusetts is running to become the top Democrat on an important House committee. His challengers Gun rights: Massachusetts has one of the country's strictest gun-control laws. But guns are ubiquitous in some towns — including Mount Katahdin deaths: Rescuers Trump administration One big bill: Trump's tax cut legislation would add $2.4 trillion to the deficit over the next decade, a nonpartisan congressional agency found. Trump has Latest salvo: Elon Musk urged Republican lawmakers Weaponizing government: Trump directed his administration to investigate Joe Biden and his aides, alleging they hid Biden's decline and that some of his actions weren't legally valid. ( Russia-Ukraine war: Trump spoke with Vladimir Putin and said the Russian leader had pledged to retaliate against Ukraine's drone attack on Russian airfields last weekend. ( Israel-Hamas war: The United States vetoed a UN Security Council resolution that called for an immediate cease-fire in Gaza. ( The Nation and the World Trans rights: Nebraska's governor signed a law banning transgender athletes from girls' sports. About half of states have similar bans. ( Overstaying their welcome: About 400,000 tourists who stayed in the United States longer than their visas allow — like the suspect in the Boulder, Colo., attack did — Explosive find: Officials in Cologne, Germany, temporarily evacuated 20,000 residents after construction work unearthed three unexploded US bombs from World War II. Experts defused them in about an hour. ( BESIDE THE POINT By Teresa Hanafin 💧 More rain this weekend: Either Boston is in 🎵 Rick Astley has the last laugh: 'Never Gonna Give You Up' has hit 1 billion streams on Spotify. 🦈 Films inspired by 'Jaws': From asthmatic sharks to 18-foot bears, here are some of the 🐔 Chicken wars: Mickey D's is bringing back the Snack Wrap after nine years because of demand — and the success of similar wraps from Burger King and Wendy's. ( 🏠 3 summer home rehabs: In downtown Burlington, Vt., Advertisement ⛱️ Beach etiquette: Don't encroach, block views, shake sand, disrespect wildlife, or do other things that are hallmarks of an obnoxious beachgoer. ( Thanks for reading Starting Point. NOTE: A 🎁 emoji indicates a gift link. A $ is a subscription site that does not offer gift links. This newsletter was edited and produced by ❓ Have a question for the team? Email us at ✍🏼 If someone sent you this newsletter, you can 📬 Delivered Monday through Friday. Ian Prasad Philbrick can be reached at
Yahoo
35 minutes ago
- Yahoo
We've finally slowed the surge in overdose deaths. The Trump admin may undo all of it
On May 14, 2025, the Division of Overdose Prevention at the Centers for Disease Control and Prevention announced that the number of overdose deaths in 2024 had dropped 27%. This was an extraordinary, even historic announcement, given overdoses had risen relentlessly for more than 33 years, resulting in the deaths of more than a million Americans, with another 1 million projected to die before this decade is over. Now, for more than a year, overdose deaths have decreased every single month, most dramatically for deaths caused by illicit fentanyl — considered the toughest problem, given the opioid's high potency, simplicity of manufacture, and ease of smuggling. That very same day, the new Secretary of Health and Human Services, Robert F. Kennedy Jr., in testimony before Congress, made no reference to overdoses, the number one killer of Americans 18 to 44 years of age, nor to the recent success. A week later, in his agency's 72-page 'Making America Healthy Again' manifesto, the word 'opioid' was never mentioned. Instead, he went on to propose that CDC should be disassembled, along with the other principal agencies responsible for addressing the overdose crisis. Those proposals, as part of the administration's 2026 fiscal year budget, passed the House and await action by the Senate. For nearly thirty years I was a CDC scientist. I have been outspokenly critical of how CDC and those other agencies have handled the opioid crisis, but the solution is not to take a wrecking ball to the institutions that protect us, particularly when we seem to be making progress. What will be the consequences? A health secretary who systematically ignores mention of the major killer of adult Americans is clearly not interested in research on what could account for a decrease in deaths. But among recent national initiatives, the push to increase availability of the opioid overdose antidote, naloxone (brand name Narcan), has clearly played a role. Between 2021 and 2023, the number of naloxone doses dispensed from retail pharmacies doubled, and millions of additional doses were distributed by harm reduction organizations. Then in March 2023, the Food and Drug Administration approved over-the-counter distribution of a nasal spray version. By the end of the year, 20 million doses had been dispensed. The decline in overdose death rates started the month after the nasal spray became widely available. Temporal sequence is not causation, but in a public health crisis, a plausible step is mass distribution of an antidote easily administered by lay persons. Few interventions in medicine are more cost-effective than saving a life in ten seconds for $25. Shortly after being put in charge of the U.S. health care system in February 2025, Kennedy, called for immediate decreased funding for naloxone. And he didn't stop there. Slated for abolition is the National Institute for Drug Abuse, the research group at the National Institutes of Health that helped develop the nasal version of naloxone. NIDA is currently researching opioid analgesics with lower addiction risk and developing wastewater detection systems to provide early warning of new illicit drugs. What is left of NIDA will be absorbed, with other decimated institutes, into a single entity focused on 'behavioral health.'Also on the chopping block is the Substance Abuse and Mental Health Services Administration, which provides the major funding for state and local naloxone distribution and drug treatment programs. CDC's Division of Overdose Prevention, which is responsible for monitoring the drug epidemic, is marked for demolition too, despite having just reported the unprecedented reduction in overdose deaths. Adding to the threat of a renewed overdose explosion, the CDC issued the stark warning of a seven-fold rise in overdoses from illicit carfentanil, an opioid 100 times more potent than fentanyl — so potent that the drug is used to sedate elephants and minuscule amounts can easily kill a person. Remnants of SAMHSA and the CDC's Division of Overdose Prevention will be folded into the new 'Agency for Healthy America." Even if we assume that every cent of the budgets of the three cancelled drug control groups is eliminated, the total reduction in the federal budget would be one-tenth of one percent, or considerably less than the cost of one aircraft carrier. According to the new director of the Office of Management and Budget, Russell Vought, these transformations should be done in a way to assure that the federal workforce will 'be traumatically affected,' and 'viewed as the villains.' What should the few remaining traumatically affected villains do about the drug crisis? Kennedy, who attributes his heroin recovery to 12-step abstinence, made that clear in his 2024 documentary: 'We're going to build hundreds of healing farms' — places where people with addiction 'learn the discipline of hard work' and 'get re-parented,' all the while bringing 'a new industry to these forgotten corners of America.' Antidotes, treatment, prevention? These are at best irrelevant — more likely, a moral hazard. The first thing you learn in public health is that all victories are temporary. Back in 2000, the CDC group where I worked demonstrated that ongoing transmission of measles — the most infectious pathogen known to humankind — had been eliminated from the U.S., thanks to nationwide hard work to raise immunization levels. A quarter-century later, because of lowered immunization levels consequent to a torrent of vaccine misinformation by Kennedy and others, there have been more than 1,000 measles cases in 30 states over the first five months of this year. The question is now before Congress: If the agencies battling the drug epidemic are disabled, will a renewed explosion of deaths result? The last time the current president was in office, overdose rates rose more than 44% over the course of his tenure — the largest overdose increase in American history, with more than 300,000 lives lost. This time, we may never know if history is repeating itself since the systems that monitor overdose deaths are themselves subject to elimination. However, families of future overdose victims may still wonder if 2025 was the year we helped make Americans die again.
Axios
an hour ago
- Axios
Questions swirl over who's running the CDC
Confusion over shifting Centers for Disease Control and Prevention COVID-19 vaccine recommendations are reigniting questions in the public health community over who's running the agency. The answer: no single person. Why it matters: Almost six months into the Trump administration, the vaunted health agency is staring down threats like respiratory viruses, avian flu and foodborne diseases without a bona fide public health official or designated point person at the helm. That's left some decisions flowing straight up to Health Secretary Robert F. Kennedy Jr. What they're saying:"You want to make sure the agency is ready should there be a public health emergency," said Richard Besser, a former acting CDC director and now head of the Robert Wood Johnson Foundation. "That's something you can't plan for, and given it can take time to get a permanent director in place, you want to make sure that the agency is able to do its work appropriately." State of play: Kennedy faced questions about the direction of the agency during a Senate hearing last month, telling Sen. Lisa Blunt Rochester (D-Del.) that Matthew Buzzelli, who's listed on the CDC website as chief of staff, is the acting director. Kennedy called Buzzelli, a former Justice Department trial lawyer and private sector executive, a public health expert, Stat reported. His biography on the CDC website lists no public health experience. President Trump in March nominated then-acting CDC director Susan Monarez, a career government scientist, to be permanent head of the agency after he withdrew the nomination of his first choice, former Rep. Dave Weldon. But under the rules governing federal vacancies, Monarez couldn't continue serving as acting director. The Senate has yet to schedule a confirmation hearing. Health and Human Services spokesperson Andrew Nixon said on Wednesday that Buzzelli is performing some director duties in the meantime. "The CDC Chief of Staff has been carrying out some of the duties of the CDC Director as the Senior Official, as necessary, and is surrounded by highly qualified medical professionals and advisors to help fulfill these duties as appropriate," Nixon told Axios in an email. Nixon didn't respond to questions about who is carrying out the rest of the responsibilities. Blunt Rochester's office told Axios that the agency hasn't furnished any more answers about who's leading CDC since the May 14 hearing. CDC employees also aren't sure who's in charge. Most external communications updates have to be approved by the office of the HHS assistant secretary for public affairs, which reports directly to Kennedy, according to one agency employee who spoke on the condition of anonymity out of fear of repercussions. The assistant secretary role is currently vacant, per the HHS website. "We're being so inefficient, so grossly inefficient, because we cannot make decisions," they said. "We're spending a lot of time planning for all these contingencies that we wouldn't normally have to plan for if we actually had some leadership." The departure of midlevel leaders, like the reported resignation this week of a career CDC physician who led the COVID vaccine recommendation work group, adds an extra layer of concern. Lakshmi Panagiotakopoulos sent a letter to work group members saying that she felt she could no longer continue to help the most vulnerable in her role, per a Reuters report. Her resignation comes after Kennedy announced that the CDC would no longer recommend COVID vaccines for healthy kids and pregnant women. The CDC later updated its guidelines to recommend that healthy kids discuss whether to get the vaccine with their doctor. "Losing that type of guidance is really hard and really demoralizing, because you know you're losing somebody that does care about the science," the CDC employee said. "The fear is the more people like that that leave, the more of a power vacuum that is, the more it leaves open for mis- and dis-information." Between the lines: In the absence of a named acting director, some official duties are being handled by Kennedy himself. Last month, Kennedy approved an expert panel recommendation for chikungunya vaccinations for travelers and lab workers, according to the agency website and first reported by Inside Medicine. Kennedy did not act on advisers' recommendations for RSV and meningitis vaccines. A federal statute known as the Vacancies Act says the that when a top agency position is vacant, the "first assistant" in the office automatically becomes acting director if no one else is named. But the statute doesn't define who the first assistant is. What we're watching: The uncertainty could continue for a while. Monarez would be the first CDC director to be confirmed by the Senate after Congress changed requirements amid post-pandemic scrutiny of the agency in 2023. The Senate health committee told Axios on Wednesday that it has not yet received all the paperwork necessary to schedule a hearing on the nomination. Another Senate staff member told Axios that Monarez has recently been making the rounds and meeting with senators. The bottom line:"CDC folks are really well equipped for dealing with uncertainty, because we work on emergency responses," the agency employee told Axios. Still, "it's hard when the internal is chaotic."
